× Industry Reports Services Press Release Contact us About us

North America Veterinary Imaging Market Forecast 2028 By End-use (Hospitals, Clinics), By Product (Veterinary Imaging Instruments [Radiography (X-ray) Systems, Ultrasound Systems, Computed Tomography Systems, Magnetic Resonance Imaging Systems, Video Endoscopy Imaging Systems, Nuclear Imaging Scanners] Veterinary Software, Veterinary Imaging Reagents [Ultrasound Contrast Reagents, MRI Contrast Reagents, X-Ray/CT Contrast Reagents, Nuclear Imaging Reagents), By Animal Type (Small Companion Animals, Large Animals), By Application (Orthopedics and Traumatology, Oncology, Cardiology, Neurology), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: January 2022 | Publisher: Graphical Research Report ID: GR2047 | Delivery : PDF  Request Free Sample

North America Veterinary Imaging Market size was valued at USD 670.5 million in 2021 and is poised to expand at 7.1% CAGR from 2022 to 2028. Surging demand for pet insurance will boost the market growth in North America.

Increasing pet adoption among the people coupled with increasing emphasis on providing quality care services for pets also contributes to the growing demand of veterinary imaging. For instance, in 2021, according to the American Pet Products Association's (APPA) National Pet Owners Survey, 151.1 million, or 70% of, households in the U.S. reported owning a pet, while spending an estimated $32.3 billion on vet care and products cumulatively.

North America Veterinary Imaging Market, By Product

The veterinary imaging instruments segment accounted for market share of 54% in 2021, owing to the increasing demand for diagnostic instruments for the proper care of pets such as dogs and cats.

Moreover, the instruments have increased sensitivity for the detection of brain hemorrhage and skull fractures, thereby making it popular among the veterinary practitioners. Additionally, the veterinary imaging instruments can also detect the brain tumor in animals.

North America Market, By Animal Type

The small companion animals segment dominated around 48.6% North America veterinary imaging market share in 2021, due to increasing adoption of small companion animals including cats and dogs coupled with increase in animal health expenditure.

Furthermore, rising burden of zoonotic diseases among the small companion animals is expected to accelerate the market demand. Moreover, rising number of veterinary practitioners in North America region will fuel the industry growth.

North America Market, By Application

 Orthopedics and traumatology segment held more than USD 239.1 million revenue in 2021. The prevalence of obesity in pet animals is increasing in this region and it is directly related to osteoarthritis in dogs and cats.

North America Market, By End-use

The hospitals segment revenue was over USD 318.6 million in 2021. Hospitals provides high accuracy result of the disease in order to provide proper and early treatment to the animals. Furthermore, hospitals are well equipped with technologically advanced veterinary imaging devices including ultrasound systems, computed tomography systems, magnetic resonance imaging systems and other imaging systems.

North America Market, By Country

U.S veterinary imaging market will showcase around 7% growth rate to reach USD 991.2 million by 2028, attributed to increasing adoption of small companion and livestock animals. Furthermore, increasing consumption of dairy products and meat in U.S. is expected to boost the market revenue. For instance, in 2018, according to the agriculture economic insights (aei), the per capita dairy products consumption in U.S. was noted to be over 640 pounds.

Competitive Industry Landscape

Prominent players in the North America veterinary imaging market are Epica International, Inc, Carestream Health, Idexx Laboratories, and GE Healthcare.

Companies are undertake various strategies such as new product launch, mergers, acquisitions, collaborations, geographic expansions to strengthen their market position. For instance, in October 2019, Epica International, Inc., a technology leader in advanced medical imaging, received 510(k) U.S. Food and Drug Administration (USFDA) clearance for its SeeFactorCT3 imaging platform. The SeeFactorCT3 is an interventional, diagnostic, and intraoperative imaging platform that obtains ultra-high-resolution 3D volumetric images.
 

Frequently Asked Question(FAQ) :

The industry share for veterinary imaging in North America was worth USD 670.5 million in 2021 and is pegged to record a 7.1% CAGR through 2028 due to the increasing need for pet insurance and the rising emphasis on offering quality care services.
Small companion animals in North America held close to 48.6% of the market share in 2021 owing to the rising adoption of cats and dogs along with the escalating animal health expenditure.
The regional market share from orthopedics and traumatology applications crossed USD 239.1 million in revenue in 2021 and will grow with the higher burden of obesity in pet animals.
The veterinary imaging industry size in the U.S. is anticipated to record more than USD 991.2 million through 2028, driven by the increasing adoption of small companion and livestock animals and the higher consumption of dairy products and meat in the country.
Epica International, Inc, Carestream Health, Idexx Laboratories, and GE Healthcare are a few of the prominent participants in the region.

Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]